Navigation Links
Hologic To Present at the Stephens Fall Investment Conference
Date:11/12/2007

BEDFORD, Mass., Nov. 12 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX) today announced that Patrick Sullivan, Executive Chairman and Glenn Muir, Chief Financial Officer, will be presenting at the Stephens Fall Investment Conference being held November 14-15, 2007 at the New York Palace Hotel in New York, NY.

Interested parties are invited to listen to a live audio webcast of Hologic's investor presentation on Wednesday, November 14, 2007 at 8:30 a.m. Eastern Time on the investor section of the Company's website at http://www.hologic.com/investor. An archive of the presentation will be available for replay following the conference.

About Hologic, Inc.

Hologic, Inc. is a diversified diagnostic and medical product and device company dedicated to serving the healthcare needs of women. Historically, we have developed, manufactured and marketed products focused on mammography, breast care and osteoporosis assessment. In October 2007, we completed our business combination with Cytyc Corporation, a company that develops, manufactures and markets a complementary product line covering a range of cancer and women's health applications, including cervical cancer screening, treatment of excessive menstrual bleeding, and radiation treatment of early- stage breast cancer. As a result of our business combination with Cytyc, we have become one of the largest companies in the world focused on creating innovative and clinically effective advanced technologies in women's health. For more information visit http://www.hologic.com.

Contact: Glenn P. Muir Frances Crecco

Executive Vice President and CFO Director, Investor Relations

Hologic, Inc. Hologic, Inc.

(781) 999-7300 (781) 999-7377


'/>"/>
SOURCE Hologic, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Does Pathological Shyness Make for School Shooters?
2. U of M study: Health food supplement may curb addiction of pathological gamblers
3. Hologic Sets Special Meeting of Stockholders to Vote on Proposed Merger with Cytyc Corporation
4. Hologic to Present at the UBS Global Life Sciences Conference
5. Hologic Acquires Biolucent, Inc.
6. Hologic Chairman and CEO to Open NASDAQ Stock Market on October 2, 2007
7. ISS Recommends Hologic Stockholders Vote FOR Merger With Cytyc
8. 1 in 5 bariatric surgery candidates not psychologically cleared for surgery
9. Hologic Stockholders Approve Merger with Cytyc
10. Exercise and psychological counseling could ease cancer-related fatigue
11. Cancer care providers need to proactively address patients psychological and social needs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... (PRWEB) , ... April 29, 2017 , ... ... celebrate the profession and recognize the positive impact veterinarians have on animal health ... and the World Organization for Animal Health (OIE) choose a theme each year ...
(Date:4/28/2017)... NC (PRWEB) , ... April 28, 2017 , ... ... announce its new partnership with the Home Care Association of America (HCAOA). This ... and Private Duty Accreditation services, as well as discounts on Accreditation University (AU) ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Beginning in ... of their formulas. This begins with the popular ClearLungs Extra Strength formula. To ensure ... changing the formula in the following ways:, , Removal of ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... distribution of the GlycoMark test throughout the Northeast U.S. , GlycoMark is ... with diabetes. The GlycoMark test provides a clinically proven one- to two-week measure ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... MINNEAPOLIS , April 20, 2017  Cogentix ... company focused on providing the Urology, Uro/Gyn and ... reported that Ash Keswani has joined the Company ... In this newly created position, Mr. Keswani will ... and CEO. "Our organization is delighted ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Market and Increasing Usage of Complex Biologics during the Forecast Period" ... ... 20 Billion in 2015 to around USD 26 Billion by 2020. ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
Breaking Medicine Technology: